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Abstract
Background: Although the occurrence, biosynthesis and possible functions of glycoproteins are increasingly
documented for pathogens, glycoproteins are not yet widely described in probiotic bacteria. Nevertheless,
knowledge of protein glycosylation holds important potential for better understanding specific glycan-mediated
interactions of probiotics and for glycoengineering in food-grade microbes.
Results: Here, we provide evidence that the major secreted protein Msp1/p75 of the probiotic Lactobacillus
rhamnosus GG is glycosylated. Msp1 was shown to stain positive with periodic-acid Schiff staining, to be
susceptible to chemical deglycosylation, and to bind with the mannose-specific Concanavalin A (ConA) lectin.
Recombinant expression in Escherichia coli resulted in a significant reduction in molecular mass, loss of ConA
reactivity and increased sensitivity towards pronase E and proteinase K. Mass spectrometry showed that Msp1 is
O-glycosylated and identified a glycopeptide TVETPSSA (amino acids 101-108) bearing hexoses presumably linked
to the serine residues. Interestingly, these serine residues are not present in the homologous protein of several
Lactobacillus casei strains tested, which also did not bind to ConA. The role of the glycan substitutions in known
functions of Msp1 was also investigated. Glycosylation did not seem to impact significantly on the peptidoglycan
hydrolase activity of Msp1. In addition, the glycan chain appeared not to be required for the activation of Akt
signaling in intestinal epithelial cells by Msp1. On the other hand, examination of different cell extracts showed
that Msp1 is a glycosylated protein in the supernatant, but not in the cell wall and cytosol fraction, suggesting a
link between glycosylation and secretion of this protein.
Conclusions: In this study we have provided the first evidence of protein O-glycosylation in the probiotic L
rhamnosus GG. The major secreted protein Msp1 is glycosylated with ConA reactive sugars at the serine residues at
106 and 107. Glycosylation is not required for the peptidoglycan hydrolase activity of Msp1 nor for Akt activation
capacity in epithelial cells, but appears to be important for its stability and protection against proteases.
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Background
The bacterial cell surface mediates many interactions
between bacteria and their changing and sometimes
harsh environment [1,2]. Diverse selective pressures are
acting on bacterial cell surface molecules, resulting in
various adaptations of their chemical and structural
composition. This is especially true for the wide array of
glycans that often can decorate bacterial cell walls and
which are collectively called the bacterial glycome [3].
Cell wall components encompassing the bacterial gly-
come can include lipopolysaccharides in Gram-negative
bacteria, glycosylated teichoic acids in Gram-positive
bacteria and peptidoglycan, exopolysaccharides, capsular
polysaccharides, glycolipids as well as glycoproteins in
both types of bacteria. Bacterial protein glycosylation
has long been overlooked, however O- and N-linked
protein glycosylation systems are increasingly being
documented among pathogenic bacteria [4-7].
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Overall interest in studying bacterial glycoproteins has
grown steadily during the past decade, with most reports
focused on the various surface structures (e.g., flagellae,
pili) related to pathogenesis [5]. In contrast, the glycopro-
teome of beneficial microbes (commensals and probiotics)
has been much less documented so far. Nevertheless,
knowledge about protein glycosylation in beneficial
microbes holds important potential for the development
of ‘safe’ glycoengineering purposes, such as enhancing the
stability and pharmacokinetic properties of therapeutic
proteins [8,9] and the design of specific immunomodula-
tory agents since glycans can mediate very specific interac-
tions, especially in microbe-host signaling [10,11].
Probiotic bacteria, such as various lactobacilli and bifido-
bacteria with documented health-promoting capacities,
are among the best candidates for these purposes. Glyco-
sylation of proteins was previously suggested in Lactoba-
cillus acidophilus [12] and Lactobacillus plantarum [2],
but without detailed analyses. Owing to its frequent use in
clinical trials [13], we study Lactobacillus rhamnosus GG
(LGG) and use it as a model probiotic bacterium for
genetic and biochemical investigations on the functional
importance of the cell surface properties of such beneficial
strains. Single molecule force spectroscopy (SMFS) experi-
ments with lectin-functionalized atomic force microscopy
tips have suggested the presence of two major types of
surface glycans in LGG [14]. The longest and most abun-
dant polysaccharides are galactose-rich, and correspond
with the galactose-rich exopolysaccharide (EPS) molecules
[15]. The shorter Concanavalin A (ConA)-reactive glycans
are yet unknown [14]. In this current study, we identified
the Msp1 (or p75) protein of LGG as a ConA-reactive gly-
coprotein, investigated its glycosylation site(s) and ana-
lyzed the functionality of the glycan component of this
protein for some of its documented biological activities.
This protein, identified previously as a major secreted pro-
tein of LGG, has been shown to have anti-apoptotic and
growth-promoting effects in intestinal epithelial cells [16].
Recently, we showed that this protein shows peptidoglycan
hydrolase activity with D-glutamyl-L-lysyl endopeptidase
specificity and is important for daughter cell separation
of LGG [17]. In our present study of Msp1, we provide -
to the best of our knowledge - the first example of an
O-glycosylated protein in the probiotic LGG.
Results
Aberrant electrophoretic migration pattern of Msp1
Msp1, described previously as the p75 protein [16], is
present in abundant amounts in the spent culture super-
natant of LGG. Interestingly, this protein appears to have
an aberrant migration pattern when analyzed by SDS-
PAGE and is detected with a significantly higher molecu-
lar mass (70-75 kDa) (Figure 1A) than the expected mass
(46.8 kDa) for a protein with a N-terminal secretion
signal (Figure 1B-C). Previously, this protein was named
(i.e. p75) based on its size on SDS gels. Because of the
apparent inconsistency in molecular mass, we have desig-
nated this protein according to its relative abundance as
Msp1 (as in the Major secreted protein). While our elec-
trophoretic results are strongly suggestive of post-transla-
tional modification, part of the observed discrepancy in
molecular mass might also be due to the disproportio-
nately high number of alanine residues (~23% content) in
the primary structure of this protein (Figure 1C). Alanine
has a low SDS-binding capacity and is known for a high
helical propensity causing slow gel migration for proteins
with high alanine content [18]. However, we found that a
msp1 mutant CMPG10200 [17] (Table 1), expressing a
truncated form of Msp1 that lacks a 311-residue C-term-
inal segment encompassing a large proportion of ala-
nines, still migrates with a larger (~45 kDa) (Figure 2B)
than expected size (16.4 kDa) (Figure 1C). Contrastingly,
the other major secreted protein of LGG (encoded by
LGG_00031 ), here renamed as Msp2 but also known
previously as p40 [16], has a predicted molecular mass of
39.7 kDa that corresponds well with its observed migra-
tion pattern on SDS gels, suggesting that this protein has
not undergone major post-translational modifications
(Figure 1A).
Msp1 visually stains as a glycosylated protein
As the first means to identify any potential carbohydrate
modifications on Msp1, proteins in the supernatant of
spent cultures of LGG were separated by SDS-PAGE and
then treated with a stain that specifically reacts with peri-
odate-oxidized carbohydrate groups (Pro-Q® Emerald 488
glycoprotein stain). As shown in Figure 2A, a ~70-kDa
stained band was detected and which we consider to be
glycosylated Msp1. However, given that this glycoprotein
stain might also cross-react with cell wall polysaccharides,
a galactose-rich EPS deficient mutant CMPG5351 [15]
and another type of cell wall polysaccharide (CW-PS)-defi-
cient mutant CMPG5413 [14] of LGG were included as
controls. As indicated by the staining results (Figure 2A),
CMPG5351 and CMPG5413 spent culture supernatants
both also displayed a similar-sized band (~70 kDa) as
wild-type LGG. Msp2 exhibited no staining above the
background level, thus further suggesting that this protein
is unlikely to be glycosylated (Figure 2A). To confirm the
covalent nature of the carbohydrate modification, and so
to exclude any possibility that glycan moieties are merely
associated with the protein, we treated Msp1 with the che-
mical deglycosylating agent trifluoromethanesulfonic acid
(TFMS) and were able to observe a clear shift in band
migration relative to untreated protein on SDS-PAGE
(Figure 2B). To provide additional evidence for glycosy-
lated Msp1, we expressed the msp1 gene in a non-glycosy-
lating E. coli host (BL21(DE3)/pLysS) and found that this
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recombinant form is significantly reduced in size when
compared to native Msp1 on SDS-PAGE (Figure 2B).
Interestingly, several discrete and smaller-sized bands
were also associated with the recombinant Msp1 sample
and subsequently confirmed to represent truncated Msp1
protein after each band was analyzed by Edman degrada-
tion, mass spectrometry (MS) (data not shown), and Wes-
tern blotting with anti-Msp1 serum (Figure 2B). The
presence of these truncated forms suggests that the
recombinant-produced Msp1 is less stable, which possibly
might be related to the alternate codon usage in E. coli.
However, given that the non-glycosylated recombinant
form appeared to be more sensitive to pronase E and pro-
teainase K than native Msp1 (Figure 2C), this is more
likely attributed to the Msp1 glycosylated protein being
more protease-resistant.
Identification of Msp1 as a ConA-reactive glycoprotein
To further confirm the glycoprotein nature of Msp1,
lectin blotting experiments were carried out. Interest-
ingly, the mannose- and glucose-specific lectin ConA
[19] reacted positively with Msp1 (Figure 2B, third
panel). Following TFMS treatment or recombinant
expression in E. coli BL21(DE3)/pLysS, this reactivity
was no longer detected for Msp1. These data were
further confirmed by testing other lectins that have
overlapping specificities, i.e. GNA from Galanthus niva-
lis and HHA from Hippeastrum hybrid (data not
Table 1 Lactobacillus strains used in this study
Lactobacillus Strain number Relevant characteristics Reference
L. rhamnosus GG (LGG) ATCC53103 Human isolate; wild-type (WT) ATCC
CMPG10200 Msp1/p75 knock-out mutant, EryR [17]
CMPG5413 Deficient in major cell wall polysaccharides (CW-PS); TcR [29-31]
CMPG5351 welE knock-out mutant; deficient in long-galactose-rich EPS; TcR [15]
L. rhamnosus ATCC7469 Dairy isolate; type strain BCCM/ATCC
L. rhamnosus GR-1 Human vaginal isolate [32]; Chr. Hansen
L. casei ATCC334 Dairy isolate, type strain BCCM/ATCC
L. casei ATCC393 Dairy isolate BCCM/ATCC
L. casei DN-114001 Dairy isolate Danone (Actimel)
Figure 1 Aberrant migration of Msp1 on SDS-PAGE compared to theoretical predictions. (A) SDS-PAGE analysis of LGG’s secreted proteins
present in spent culture supernatant after overnight growth in AOAC medium. The proteins in lane 1 correspond to the molecular mass
standard (Candy Cane). Lane 2 corresponds to the secreted proteins of LGG WT. Arrows indicate the major secreted proteins of LGG. Msp1 was
confirmed by Edman degradation and MS/MS to correspond to LGG_00324 (YP_003170070). Msp2 was confirmed by Edman degradation and
MS/MS to correspond to LGG_00031 (YP_003169777). The gels are stained with Sypro® Ruby. (B) Genomic context of the msp1 gene
(LGG_00324). (C) Amino acid sequence of Msp1. The underlined amino acids indicate the signal peptide that is cleaved off after secretion.
Additionally, the theoretical trypsin digest is depicted (indicated by ||). The theoretical mass and pI after cleavage of the signal peptide are
respectively 6.06 and 46779 Da. Peptides that were experimentally identified by Edman degradation or MS/MS analysis are indicated in bold. As
trypsin digestion yields long peptide fragments, this complicated the identification of multiple peptides. The truncated form of Msp1 which is
expressed in the msp1 mutant CMPG10200 is indicated in between the triangles (▼).
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shown). Given that all the above lectins interact with
terminal mannose residues [20], other lectins with dif-
ferent specificities, such as fucose (from Ulex europaeus)
and sialic acid (MAA from Maackia amurensis and
SNA-I from Sambucus nigra), were also used but these
failed to react (data not shown). Monosaccharide com-
ponent analysis confirmed the presence of mannose in
this glycoprotein and absence of fucose and sialic acid
(data not shown). The C-terminally truncated form of
Msp1 of the CMPG10200 mutant appeared to be still
reactive with ConA (Figure 2B, third panel), suggesting
that the ConA-reactive glycosylation site(s) are confined
to the N-terminal part.
Msp1 is O-glycosylated at S106-S107
Glycosylation of Msp1 was further analyzed by MS of
(glyco-)peptides. Gel bands containing Msp1 were sub-
jected to reduction, alkylation, and trypsin treatments
Figure 2 Identification of Msp1 as a glycoprotein. (A) SDS-PAGE analysis of LGG’s secreted proteins present in spent culture supernatant after
overnight growth in AOAC medium. The secreted proteins of LGG WT, msp1 mutant, EPS mutant CMPG5351 and CW-PS mutant CMPG5413 are
included. Arrows indicate the major secreted proteins of LGG Msp1 and Msp2 confirmed by Edman degradation and MS/MS. The gels are
stained with Sypro® Ruby and ProQ Emerald glycoprotein stain. (B) Comparative analysis of the glycosylation of Msp1 in spent culture
supernatant of LGG wild-type before and after treatment with TFMS, and after recombinant expression in E. coli. The msp1 mutant CMPG10200
was included as a control. This mutant expresses a C-terminally truncated form of Msp1 and lacks the enzymatic active NlpC/P60 domain [17].
SDS-PAGE gels were compared by ConA lectin blotting and blotting with Msp1 specific antiserum. (C) Comparison of the sensitivity of
recombinant non-glycosylated Msp1 purified from E. coli (rec. Msp1) and native glycosylated Msp1 purified from LGG WT (glyc. Msp1) towards
pronase E and proteinase K. Protein samples were incubated for 1 h at 37°C with the indicated diluted preparations of proteases (Sigma). SDS-
PAGE gels were stained with Sypro® Ruby (Invitrogen). Images were scanned with Typhoon 9400 (GE Healthcare).
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and the resulting peptides were analyzed by reversed
phase-LC-ion trap-MS/MS. Evaluation of fragmentation
spectra together with searches of public databases
(NCBI) gave partial coverage of the Msp1 protein
(gi199599310). Most peptides with sizes larger than 600 Da
and smaller than 8000 Da were identified by either data-
base searching or manual interpretation (Table 2). The
manual interpretation of the LC-MS/MS data revealed gly-
copeptide clustering that appears as [M+4H]4+, [M+5H]5+ ,
and [M+6H]6+ ions (Figure 3A). As was determined by
tandem MS, glycopeptides differed in the number of
hexoses attached to the peptide moiety, which was
reflected by a mass difference of 162 Da. As an example,
the fragmentation spectrum of m/z 1165.4 [M+5H]5+ is
shown in Figure 3B. The peptide species is identified as
T99ATVETPSSAASQTAVSQAPASQAPTSQAPATQT-
PAAPQTDTQTANTQLYVK150 and was found to carry
four hexoses. The y ions as well as the b6 ion confirm the
identity of these glycopeptides. While most fragment ions
including all y ions were observed without the hexoses
being attached, the b19 cleavage product was registered
without hexoses (m/z 1788.8), with 1 hexose (m/z 1950.8),
and with 2 hexoses (m/z 2112.8), indicating that at least
part of the hexoses is linked to the N-terminal portion of
this peptide fragment. These data demonstrate that the gly-
cosylation on Msp1 varies from two to five hexoses linked
to T99K150.
Since the very large tryptic peptides of Msp 1 (F204R378,
MW15931.57 and G403K481, MW 8257.93) could not be
detected by MS, they were first digested by proteinase K
and then further subjected to analysis for glycosylation.
However, because proteinase K treatment is known to
often result in glycopeptides made up of small peptide
moieties (up to 10 amino acid residues) [21] that show no
or insufficient retention in reverse phase LC, further analy-
sis was instead performed by graphitized carbon-LC-ion
trap-MS/MS. As a result, a group of glycopeptides could
be registered that were substituted with one or two hexose
residues. As an example, the fragmentation of peptide
T101VETPSSA108 substituted with 2 hexose residues is
shown in Figure 4. A glycosylated y4 fragment ion contain-
ing two hexose residues (m/z 685.4) allows the assignment
of the hexoses to the S106-S107 dipeptide. The other glyco-
peptides T104PSSA108, T101VETPSSA108 and T101VETPS-
SAA109 or A100TVETPSSA108 with one or two hexose
residues also covered the same S106-S107 dipeptide. No gly-
copeptides were registered covering parts of the large tryp-
tic peptides of F204R378 and G403K481.
Table 2 Sequence coverage of Msp1.Tryptic peptides were registered by RP-LC-ion trap-MS/MS. Filled circles indicate
hexoses
(Glyco)peptide Registered signal (m/z) Calculated mass/determined mass Mascot score
S33K40 Not detected 841.42/-
S41K56 595.48 [M+3H]
3+ 1783.41/1783.44 60
R57 Not detected 174.11/-
Y58K81 720.90 [M+2H]
2+ 1439.78/1439.80 90
T71K81 641.78 [M+2H]
2+ 1281.54/1281.56 68
V82K98 639.34 [M+3H]
3+ 1914.99/1915.02 46
T99K150 Not detected 5170.51/-
T99K150 ●● 1374.56 [M+4H]
4+
1099.81 [M+5H]5+
916.81 [M+6H]6+
5494.62/5494.35 Manually assigned
T99K150 ●●● 1415.06 [M+4H]
4+
1132.31 [M+5H]5+
943.75 [M+6H]6+
5656.67/5656.43 Manually assigned
T99K150 ●●●● 1455.55 [M+4H]
4+
1164.69 [M+5H]5+
970.75 [M+6H]6
5818.72/5818.38 Manually assigned
T99K150 ●●●●● 1496.25 [M+4H]
4+
1197.13 [M+5H]5+
997.88 [M+6H]6+
5980.77/5980.98 Manually assigned
N151R193 1168.50 [M+4H]
4+ 4669.25/4669.0 Manually assigned
L194R203 509.24 [M+2H]
2+ 1016.46/1016.48 49
F204R378 Not detected 15931.57/-
Q379K381 Not detected 345.20/-
I382K402 752.78 [M+3H]
3+ 2255.32/2255.34 92
G403K481 Not detected 8257.93/-
Y482L498 989.46 [M+2H]
2+ 1976.90/1976.92 90
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ConA reactivity correlates with presence of the S106-S107
dipeptide in L. rhamnosus but not in L. casei strains
Multiple-sequence alignment analysis of the primary
structure of Msp1 (p75) from different L. rhamnsosus
and L. casei strains suggested that the amino acid resi-
dues of the T104PSSA108 fragment covering the S106-S107
dipeptide in Msp1 of L. rhamnosus strains are replaced
with A104PEQT108 in several L. casei strains [22]. To
determine whether this is a factor in ConA reactivity,
parallel experiments were performed involving ConA
and anti-Msp1 serum blotting (Figure 5A) with spent
culture supernatant proteins from different L. casei and
L. rhamnosus strains that were obtained from our
laboratory collection (Table 1). All samples tested from
L. rhamnosus and L. casei appeared to exhibit a protein
that is recognized by the antiserum raised against
recombinant LGG Msp1, although the molecular mass
of the Msp1-like proteins in the L. casei strains tested
seems to be smaller than Msp1 in the L. rhamnosus
strains (Figure 5A). Results from blotting experiments
with ConA indicated that only the Msp1 proteins of the
L. rhamnosus strains confirmed to have the S106-S107
dipeptide (Figure 5B) display the capacity to interact
with ConA (Figure 5A).
Msp1 glycosylation is not crucial for Akt activation of
LGG Msp1 in Caco-2 cells
Previously, Msp1 (or p75) was identified by Polk and co-
workers as a soluble protein of LGG that can regulate
intestinal epithelial cell survival and growth via Akt sig-
naling [16]. Here, we investigated what role the glycan
chain of Msp1 plays in Akt activation in the Caco-2
intestinal epithelial cell line. To do this, both purified
and TFMS-deglycosylated Msp1 and recombinantly pro-
duced Msp1 were used. As shown in Figure 6, no signif-
icant difference in Akt activation was found for the
glycosylated and non-glycosylated forms. The msp1
mutant still showed Akt activation, which likely reflects
the presence of Msp2, which is a stronger activator of
Akt signaling than Msp1 [16].
Figure 3 Analysis of tryptic Msp1 glycopeptides by mass spectrometry. (A) Sum mass spectrum of the elution range of tryptic
glycopeptides T99K150 carrying two to five hexose residues. Glycopeptides were detected with four, five, and six charges. (B) Ion trap-MS/MS of
T99K150 carrying four hexoses ([M+5H]
5+ at m/z 1165.4). The MS/MS spectrum was acquired by nano-LC-MS/MS of the total tryptic digest of Msp
1. The Ser-Ser motif which was found to be substituted by hexoses is highlighted in blue. Filled circle indicates hexose.
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Figure 4 Tandem mass spectrometry of the proteinase K-generated peptide T101VETPSSA108 carrying two hexoses. The MS/MS
spectrum of m/z 1115.9 [M+H]+ was acquired by graphitized carbon nano. The Ser-Ser motif which was found to be substituted by hexoses is
highlighted in blue. Filled circle indicates hexose.
Figure 5 Comparative analysis of the glycosylation of Msp1 in L. rhamnosus and L. casei strains. (A) Supernatant proteins from different L.
rhamnosus and L. casei strains were run on SDS-PAGE and stained with Sypro® Ruby, and transferred to PVDF membranes for Western blot
analysis with Msp1 antiserum or ConA lectin. (B) Multiple alignment of part of the Msp-1 like proteins in different L. casei and L. rhamnosus
strains. The corresponding msp1 genes were obtained by sequencing after PCR as described in the Methods section. The glycosylation site on
the S106-S107 dipeptide determined by MS/MS for LGG is indicated with asterisks.
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Msp1 glycosylation is not crucial for peptidoglycan
hydrolase activity of Msp1
Recently, we demonstrated that Msp1 is a peptidoglycan
hydrolase with D-glutamyl-L-lysyl endopeptidase activity
[17]. Here, we aimed to determine whether glycosylation
is required for the peptidoglycan hydrolase activity by
comparing the native (glycosylated) and recombinant
(non-glycosylated) forms of Msp1. Our zymogram ana-
lyses indicated that Msp1 in spent culture supernatant
and both purified native and recombinant Msp1 all
share the same level of activity (Figure 7). However, the
msp1 mutant CMPG10200, which expresses a truncated
Msp1 protein that lacks the important catalytic NlpC/
p60 domain, was not active in agreement with our pre-
vious results [17].
Msp1 glycosylation is linked with localization in the
supernatant
To ascertain whether a link exists between the cellular
location and the glycosylation of Msp1, we isolated pro-
teins from the spent culture supernatant, cell wall, and
cytosol, and performed parallel blotting experiments
with ConA and anti-Msp1 serum. As our results indi-
cate, although Western blotting with Msp1-specific anti-
serum confirmed the presence of Msp1 in all cellular
fractions, the cytosolic and cell wall fractions showed no
significant reactivity with ConA, unlike the spent culture
supernatant fraction which did exhibit strong ConA
reactivity (Figure 8).
Discussion
In this study, we have reported the presence of an O-gly-
cosylated protein in a probiotic Lactobacillus strain. LGG’s
major secreted protein Msp1, which we renamed from p75
Figure 6 Impact of Msp1 glycosylation on Akt activation in intestinal epithelial cells. Caco-2 cells were co-incubated with L. rhamnosus GG
wild-type (107 CFU/ml), msp1 mutant CMPG10200 (107 CFU/ml), glycosylated Msp1 after purification with affinity chromatography and ConA
sepharose (ca. 100 ng/ml), Msp1 partially purified from spent culture supernatant (SN) (ca. 10 ng/ml), chemically deglycosylated Msp1 after TFMS
treatment (ca. 100 ng/ml) and recombinantly (rec.) expressed Msp1 after purification from E. coli (ca. 100 ng/ml). Subsequent Akt activation was
monitored by Western blot analysis of cellular lysates with anti-P-Akt and ant-Akt antibodies. Data are representative for 2 separate experiments.
Figure 7 Impact of Msp1 glycosylation on peptidoglycan
hydrolase activity. The cell wall hydrolyzing capacity of
glycosylated (glyc.) and recombinant (rec.) non-glycosylated Msp1
was determined with msp1 mutant CMPG10200 cells as substrate.
Supernatant (SN) samples from LGG wild-type (WT) and the msp1
mutant CMPG10200 were also loaded on the zymogram gels. The
gels were incubated overnight at 37°C in phosphate buffer
containing 1 mM DTT supplemented with the different Msp1
samples and visualized by methylene blue staining as described in
materials and methods.
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[16], has been shown previously to mediate intestinal cell
homeostasis through Akt signaling pathways, but also
exhibits an interesting aberrant gel migration pattern. To
provide evidence for the glycosylation of Msp1, we used a
combination of several standard glycosylation detection
methods, which include periodate-oxidation, chemical
deglycosylation with TFMS, and lectin blotting with
ConA, which is specific for mannose or glucose residues.
Moreover, we demonstrated that a recombinant form of
Msp1, which was produced in a non-glycosylating E. coli
host, has a significantly reduced molecular mass and can-
not bind to ConA. In addition, we also found that recom-
binant Msp1 was less stable than the native form. Mass
spectrometry experiments confirmed that Msp1 is indeed
O-glycosylated and identified a glycopeptide fragment
(T101VETPSSA108) that displays at least two hexose moi-
eties on S106-S107. These data do not allow distinguishing
between the following possibilities: the occurrence of two
single hexoses attached to serine residues, or the presence
of a disaccharide substituent. In addition, larger glycopep-
tides species where observed that covered the same S106-
S107 glycosylation site(s) and carried up to 5 hexoses. The
obtained fragmentation spectra did not allow the assign-
ment of the hexoses to specific sites. The observed glyco-
peptides T99-K150 are rich in serine and threonine
residues, which both represent potential hexose attach-
ment sites. Although some y ions representing only
the peptide backbone have been detected in the MS/MS
spectra of these glycopeptides, the existence of di-, tri-,
tetra- or pentahexosyl units attached to Msp 1 remains
speculative since no corresponding glycan oxonium ions
were observed (e.g. no [hexose2+H]
+ signal at m/z 325).
However, based on the fragmentation spectrum of the
tryptic glycopeptides, the occurrence of such oligosacchar-
ide moieties cannot be excluded. With regard to the nat-
ure of the hexose units, the above-mentioned Con A
binding in combination with the binding to GNA from
Galanthus nivalis and HHA from Hippeastrum hybrid
(mannose specific lectins) indicate these to be mannose
residues. Additional research is required to completely
characterize the O-glycans and exact glycosylation sites of
Msp1.
Interestingly, in the homologous forms of Msp1 in sev-
eral L. casei strains tested, which do not react with ConA,
these serine residues are missing, thus underscoring their
importance as glycosylation sites in Msp1 of LGG (and
other L. rhamnosus strains) and the basis for ConA reac-
tivity. However, this does not exclude the possibility that
the Msp1-like proteins of L. casei are glycosylated at other
sites with other sugars. In fact, preliminary lectin blotting
experiments suggest glycosylation of Msp1 in L. casei with
galactose or N-acetylgalactosamine residues. Thus, our
results are strongly suggestive of a species-specific glycosy-
lation mechanism for Msp1 in different L. rhamnosus
bacteria.
Subsequently, we investigated the role of the glycan
chain in functions established previously for Msp1 of
L. rhamnosus GG, which include the activation of Akt
signaling in intestinal epithelial cells [16] and a peptigly-
can hydrolase activity [17]. Our results indicate that gly-
cosylation of Msp1 does not appear to be crucial for
either of these two functions. The lack of a direct role for
the glycosylation of Msp1 in its activation of Akt signal-
ing is not surprising, given that Msp2, as an apparently
Figure 8 Relationship between Msp1 glycosylation and cellular location. LGG wild-type was grown for 24 h in AOAC medium and proteins
were isolated from spent culture supernatant, the cell wall and cytosol fraction as described in Materials and Methods. Samples were run on
SDS-PAGE and blot with Msp1 antiserum or ConA lectin. For comparison, non-glycosylated recombinant Msp1 (rec. Msp1) was included.
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non-glycosylated protein (this study), can also activate
Akt in intestinal epithelial cells and at lower concentra-
tions than does Msp1 (p75) [16]. However, this does not
exclude a possible modulating role for the Msp1 glycan
chains in Akt activation. For instance, these glycan com-
ponents might still act to shield host cell receptors and,
in so doing, possibly cause a reduction in the capacity of
Msp1 and IECs to interact, thus modulating the extent of
Akt signaling. The finding that the specific ConA-reactive
glycosylation of Msp1 is not required for peptidoglycan
hydrolase activity is in full agreement with the fact that
the L. rhamnosus GG and L. casei BL23 Msp1-like pro-
teins both exhibit identical enzymatic properties [17,23],
while the glycosylation site T101VETPSSA108 in L. rham-
nosus GG Msp1 is replaced with T101VQAPEQY108 in
the Msp1-like protein in L. casei BL23 [22] and the Msp1
proteins of the L. casei strains used in our study do not
show ConA reactivity.
The protein glycosylation machinery of L. rhamnosus
GG is currently unknown. Our data related to the cellular
localization of Msp1 in L. rhamnosus GG reveal a possible
link between the glycosylation of Msp1 and its release into
the surrounding milieu. Furthermore, lectin blotting
experiments indicate that other secreted proteins, includ-
ing the putative cell wall hydrolase encoded by
LGG_02225 might be glycosylated, suggesting a more glo-
bal mechanism (data not shown). This would be in agree-
ment with the fact that there appear to be no neighboring
genes of the msp1 gene that putatively encode for glycosyl-
transferases, in contrast to dedicated protein glycosylation
systems [7]. Our future experiments will include determin-
ing the exact glycosylation mechanisms and the role of
glycosylation of Msp1 and related proteins in the control
of their activity and localization. The function of glycosyla-
tion for Msp1 might possibly be similar to that which was
reported for the HMW1 protein in Haemophilus influ-
enza, which includes the protection against premature
degradation and the tethering of protein to the cell surface
[24]. In addition, various specific C-type lectin receptors of
the innate immune system, such as the dendritic cell-spe-
cific intercellular adhesion molecule-3-grabbing non-
integrin DC-SIGN [10,25], show a sugar specificity that
overlaps with ConA. Future experiments are also aimed at
elucidating the role of Msp1 glycosylation in innate
immune signaling.
Conclusions
In this study we have provided convincing evidence that
Msp1 (p75) of the probiotic L. rhamnosus GG is O-glyco-
sylated with ConA-reactive sugars at the serine residues in
T101VETPSSA108 once released into the external sur-
roundings. Further studies are now required to determine
the exact glycan chain, mechanism and functional impor-
tance of glycosylation in Msp1. Nonetheless, the first
identification of a glycosylation site in a probiotic-related
protein provides interesting opportunities in a safe and
food grade bacterium for glyco-engineering purposes such
as targeting specific immune cells or enhancing the
stability.
Methods
Bacterial strains and culture conditions
Lactobacilli (Table 1) were grown at 37°C in MRS med-
ium (Difco) or in Lactobacilli AOAC medium (Difco) in
non-shaking conditions. CMPG10200 was grown in the
presence of 5 μg/ml erythromycin for stable mainte-
nance of the integrative plasmid. In addition, Escherichia
coli strains TOP10 [F- mcrA Δ(mrr-hsdRMS-mcrBC)
F80lacZ ΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu)7697
galU galK rpsL (StrR) endA1 nupG] and BL21(DE3)/
pLysS [F- ompT hsdSB(rB- mB-) gal dcm (DE3) pLysS
(CamR)] were used for plasmid preparation and protein
expression, respectively. E. coli was routinely grown in
Luria-Bertani (LB) medium at 37°C with agitation and
was supplemented with 50 μg/ml kanamycin when
required.
Molecular cloning
Standard DNA protocols were used for molecular cloning
and related procedures as described previously [18].
Sequencing of the msp1 gene from different L. rhamnosus
and L. casei strains (Table 1) was performed on PCR pro-
ducts obtained by colony PCR with primers Pro-0997
(5’ATGAATTCACAGGGACGGTCAGTTACAAATCC-
3’, EcoRI site underlined) and Pro-0998 (5’-ATGA
ATTCGTTGTTCGGCAATGGCAATCACTG-3’, EcoRI
site underlined) for L. rhamnosus and Pro-0679 (5’-
AGAAAGTATTGTCAGTAACGGCAGG-3’) and Pro-
0680 (5’-TTGGCAAGCCGATACCATGTTTCAC-3’) for
L. casei strains by Macrolon (The Netherlands). These
DNA sequences were translated to amino acid sequence
and a multiple alignment around the S106-S107 dipeptide of
LGG was constructed using the Geneious Pro™ software.
Production of purified recombinant Msp1 protein
The coding sequence for msp1 (LGG_00324) not including
the sequence for the N-terminal signal peptide was ampli-
fied by PCR from LGG genomic DNA by means of two
flanking 5’- and 3’-end oligoprimers, one with an EcoRI
restriction site (5’- TACCGTTTCGAATTCGACAGG-
GACGGTC-3’, EcoRI site is underlined]) and another
with an XhoI restriction site (5’- GATCATTAAGCCTC-
GAGTGACGGGCGAAC-3’, XhoI site is underlined) (Oli-
gomer, Finland). The EcoRI- and XhoI-digested PCR
fragment was ligated into the pET28b+ expression vector
(Novagen) and the resulting recombinant plasmid
(pKTH5316) then propagated in the E. coli strain BL21
(DE3)/pLysS for cytosolic production of C-terminal
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hexahistidine-tagged protein. Recombinant Msp1 (48.4
kDa) also consists of an additional seven N-terminal- and
two C-terminal-located amino acids, all of which originate
from the coding sequence of the expression vector.
Recombinant Msp1 production was carried out as
described previously [17]. Briefly, E. coli cells with
pKTH5316 were cultivated at 37°C in LB-kanamycin
(50 μg/ml) broth, and at the mid-log phase they were then
induced by 1 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG) and grown for another 3 h to allow the accumula-
tion of recombinant Msp1. After cells were pelleted by
centrifugation, they were sonicated in lysis buffer (50 mM
NaH2PO4 [pH 8.0], 300 mM NaCl, 10 mM imidazole) and
the broken cell suspension that resulted was then clarified
by centrifugation and membrane-filtering (0.45-μm pore-
size). The clarified suspension was added to a nickel nitri-
lotriacetic acid (Ni-NTA) agarose (Qiagen) column and,
following rinsing with wash buffer (50 mM NaH2PO4 [pH
8.0], 300 mM NaCl, 20 mM imidazole), recombinant
Msp1 was recovered with elution buffer (50 mM
NaH2PO4 [pH 8.0], 300 mM NaCl, 250 mM imidazole).
Elution buffer was exchanged to 10 mM Tris-HCl (pH
8.0) with a Bio-Rad EconoPac 10 DG desalting column
and purified Msp1 was then concentrated using a 30-kDa
Microsep filter (Pall Life Sciences).
Production of anti-Msp1 serum
Polyclonal antiserum was raised against purified recom-
binant Msp1 in rabbit as described previously [17]. In
brief, a 1:1 mixture of 400 μg Msp1 and Freund’s com-
plete adjuvant (1-ml volume) was first administered sub-
cutaneously and then followed by additional 1 ml
booster injections (200 μg Msp1 and Freund’s incom-
plete adjuvant as a1:1 mix) every 3 weeks for a total of
9 weeks. Fourteen days after the final booster injection,
blood was recovered for antiserum preparation as
described elsewhere [26].
Western blot
For Western blot experiments, equivalent amounts,
determined by a bicinchoninic acid (BCA) assay, of pro-
tein were separated by SDS-PAGE and subsequently elec-
troblotted onto polyvinyldifluoride (PVDF) membrane.
The PVDF sheets were blocked with 3% bovine serum
albumine (BSA) in TBS (20 mM Tris-HCl, 500 mM
NaCl, pH 7.5) and incubated at room temperature with
Msp1 antiserum (1:7500 to 1:15000) for 1 h. After several
washings with TBS, blots were incubated for 1 h with
goat anti-rabbit antibodies conjugated with alkaline phos-
phatase (Sigma) at a dilution of 1:1000. Detection was
performed with nitro blue tetrazolium and bromo-chloro
indolyl phosphate as substrate and the blue coloring
reaction was monitored.
Isolation of different protein fractions from LGG
(1) supernatant. LGG bacteria were grown for 24 h in
AOAC-medium. After centrifugation (6000 g, 20 min),
proteins were precipitated from supernatant by incubation
at 4°C for 30 min in the presence of trichloro acetic acid
(20% final concentration). After centrifugation (9000 g,
20 min), precipitated proteins were washed twice with
cold acetone. Pellet was air-dried and proteins were resus-
pended in lysis buffer (2 M thio-urea, 7 M urea, 4%
CHAPS, 2% DTT). (2) cell wall. After centrifugation
(6000 g, 20 min) and washing with PBS, bacteria were
sonicated in PBS buffer (Branson sonifier) until lysis was
observed (several minutes at 10% power). Lysate was
cleared by centrifugation (3 times at 4000 g). Cell wall pro-
teins were precipitated by ultracentrifugation (22000 g for
45 min). Pellet was washed 3 times with 50 mM Tris pH8,
500 mM NaCl and dissolved in a small volume PBS. (3)
cytosol. After centrifugation (6000 g, 20 min), the pellet
was washed 2× with 0.9% NaCl. Subsequently, the pellet
was dissolved in 1 ml 100 mM Tris, 1% SDS, pH 9.5
and sonicated for 3 min (0.5” on, 1.5” off) with a Branson
sonifier. Subsequently, cell debris was removed by centri-
fugation and proteins were precipitated with TCA precipi-
tation, two times washed with ice-cold 100% acetone,
air-dried and then dissolved in PBS.
Purification of the L. rhamnosus GG Msp1 protein
The p75/Msp1 protein was partially purified by cationic
exchange as described previously [16]. Hereto, L. rhamno-
sus GG was grown for 24 h in AOAC medium, after
which spent culture medium was collected (6000 g,
20 min). The culture supernatant was then loaded onto a
SP Sepharose HighPerfomance column (GE Healthcare),
equilibrated with 60 mM lactate buffer pH 4.0. Bound pro-
teins were eluted using lactate buffer containing sequential
NaCl concentrations (100-1000 mM). Fractions positive
for the presence of Msp1 were identified using SDS-PAGE
and spin concentrated using Vivaspin filters with MW cut
off 10.000 (Sartorius Stedim biotech GmbH, Germany).
For the MS/MS experiments, Hi-trap ConA 4B prepacked
columns (GE Healthcare) were used according to manu-
facturer’s instructions to further purify positive fractions.
Characterization of glycan nature of the p75/Msp1
protein
(i) ProQ Emerald glycoprotein stain. Samples were
loaded onto the wells of the SDS-containing gel after
adding buffer and reducing agent according to manufac-
turer’s instructions from the Pro-Q Emerald 488 Glyco-
potein Gel and Blot stain kit (Molecular Probes,
Invitrogen). (ii) Treatment with TFMS. Msp1 was che-
mically deglycosylated by the TFMS method as
described before [27] at -20°C for 30 min. After
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treatment, the proteins were extensively dialyzed and
then analyzed by SDS-PAGE. (iii) Lectin blotting. The
proteins were electroblotted onto PVDF membrane
similar as for Western blot. After blocking, the PVDF
sheets were incubated at room temperature with lectins
conjugated with biotin (biotinylated ConA, WGA or
Ulex europaeus, Sigma-Aldrich or GNA, HHA, MAA
SNA-I purified and biotinylated according to [20] for 1 h
at final concentrations of 0.25 μg/ml in the presence of
1 mM Mg2+ and 1 mM Ca2+ ions. After washing, blots
were incubated for 1 h with streptavidin conjugated with
alkaline phosphatase (Roche) at a dilution of 1:1000.
Detection was performed as described for Western
blotting.
MS determinations
The LGG Msp1 protein purified by cation exchange chro-
matography was applied to SDS-PAGE using Nu-Page
4-12% gradient Bis-Tris (Invitrogen) gels. The excised gel
pieces containing Msp1 were reduced, alkylated and
digested with trypsin (Promega), as previously described
[28] or with Proteinase K (from T. album; Sigma-Aldrich)
[21]. After digestion, (glyco-)peptides were collected using
two rounds of extraction with 20 μl of 0.1% trifluoroacetic
acid and stored at -20°C prior to analysis by mass spectro-
metry. The total tryptic digest of Msp1 was applied to a
reverse phase column (PepMap, 3 μm, 75 μm·x 100 mm;
Dionex/Thermo Fisher, Waltham, MA) using an Ultimate
3000 nano-LC system (Dionex/Thermo Fisher). The col-
umn was equilibrated at RT with eluent A (0.1% formic
acid in water) at a flow rate of 300 nl/min. After injection
of the sample a linear gradient was applied (15 min 25%
eluent B (95% acetonitrile), 25 min 70% B, 30 min 70% B).
The eluate was monitored by absorption at 215 nm. The
LC column was coupled to an Esquire HCT-Ultra ESI-ion
trap-MS (Bruker Daltonics, Bremen, Germany) equipped
with an online nanospray source operated in the positive
ion mode. For electrospray (1100-1250 V), electropolished,
stainless steel LC-MS emitters (150 μm OD, 30 μm ID)
from Proxeon A/S (Odense, Denmark) were used. The sol-
vent was evaporated at 170°C employing a nitrogen stream
of 6 l/min. When operated in the auto MS/MS mode,
monitoring ions from m/z 500 to 1600, each MS scan was
followed by the acquisition of MS/MS spectra of up to five
of the most abundant ions in the MS spectrum.
The digest generated by Proteinase K was separated
using an Ultimate 3000 nano-LC system (Dionex/
Thermo Fisher) equipped with a graphitized carbon trap
column (Hypercarb, 5 μm, 170 μm × 10 mm; Thermo
Scientific) and nano column (75 μm x·100 mm) packed
by Grom Analytik (Rottenburg, Germany). The column
was equilibrated at RT with eluent A (0.1% formic acid in
water) at a flow rate of 400 nl/min. After injection of the
sample a linear gradient was applied (15 min, 25% eluent
B (95% acetonitrile); 25 min, 70% B; 30 min, 70% B). The
eluate was monitored by absorption at 215 nm. Eluates
were analyzed by ESI-ion trap-MS as described above.
The ions were monitored from m/z 300 to m/z 1500 in
the MS mode. The MS/MS spectra were analyzed with
Data Analysis (Bruker Daltonics), converted to MGF files
and searched against NCBI database, with search limita-
tion “bacteria” using the MASCOT search algorithm.
Carbamidomethylation of cysteines was set as a fixed
modification and oxidized methionines were set as a vari-
able modification. Trypsin was specified as the proteoly-
tic enzyme and missed cleavages were not allowed. The
mass tolerance of the precursor ion was set to 2 Da and
that of the fragment ions was set to 0.5 Da. In addition,
MS/MS spectra were used for manual interpretation and
de novo sequencing.
Activation of Akt in Caco-2 cells
Caco-2 cells were cultured as described before [15]. 24 h
before the experiments, the Caco-2 cells were deprived of
FBS. LGG wild-type was grown overnight in AOAC med-
ium, centrifuged at 4000 × g and 4°C for 10 min, and
washed with cold PBS. Caco-2 cells were incubated with
1.5 ml of DMEM without FBS containing either 1 × 107
CFU/ml LGG wild-type or msp1 mutant CMPG10200,
100 ng/ml wild-type, recombinant or TFMS-treated Msp1.
DMEM without FBS was used as a negative control. After
16 h incubation at 37°C, cell lysates were made with
HEPES-lysis buffer containing 25 mM HEPES pH 7.5,
0.3 M NaCl, 1.5 mMMgCl2, 20 mM b-glycerol-phosphate,
2 mM EDTA, 2 mM EGTA, 1 mM DTT, 1% (v/v) Triton
X-100, 10% (v/v) glycerol, 10 μg/μl leupeptin, 5 μg/μl
aprotinin, 1 mM PMSF, 1 mM Na3VO4 and 50 mM NaF.
Protein concentration was determined using BCA assay
(Perbio, Thermo Fisher Scientific). Samples with loading
buffer were prepared and processed on the CriterionTM
system (Bio-Rad Laboratories, Hercules, CA, USA) on a
4-12% Bis-TRIS gel (Biorad) and Protran 2 μm-pored
nitrocellulose membrane (Perkin-Elmer, Wellesley, MA,
USA). Membranes were blocked for 1 h at room tempera-
ture in Tris-buffered saline containing 0.1% Tween-20 and
5% BSA. The membrane was incubated overnight at 4°C
with the primary antibody diluted in 5% BSA in 1× TBS
plus 0.1% Tween 20, then washed 3 times with TBS plus
0.1% Tween 20, followed by incubation with the second
polyclonal antibody for 2 h at 4°C. Antibodies against
phospho-AKT (Ser473) and total AKT were obtained
from Cell Signaling Technology (Beverly, MA).
Zymogram analysis
The cell wall hydrolyzing activity was investigated by
zymogram analysis as described previously by Lepeuple
et al. (14). SDS-PAGE was performed with 10% (w/v)
polyacrylamide separating gels (NuPage, Invitrogen).
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Autoclaved LGG cells treated with 10% TCA were
added to the gels as enzyme substrates and the gels
were loaded with 10 to 20 μg of protein samples. After
sample migration, the gels were washed for 30 min in
deionized H2O at room temperature and then incubated
in a phosphate buffer, pH 6.2, 1 mM dithiothreitol
(DTT) containing 0.1% (v/v) Triton X-100, overnight at
37°C. The gels were subsequently washed for 30 min in
deionized H2O, then stained with 0.1% methylene blue
in 0.01% (w/v) KOH for 2 h at room temperature and
destained in deionized H2O.
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